Cardiovascular effects and safety of (non-aspirin) NSAIDs

AM Schjerning, P McGettigan, G Gislason - Nature Reviews Cardiology, 2020 - nature.com
Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely used analgesics. For
the past 2 decades, considerable attention has been focused on their cardiovascular safety …

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of …

M Schmidt, M Lamberts, AMS Olsen… - European heart …, 2016 - academic.oup.com
Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) have been used in clinical
practice for more than a century and are among the most widely used drugs worldwide for …

[HTML][HTML] Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks

IL Meek, MAFJ Van de Laar, HE Vonkeman - Pharmaceuticals, 2010 - mdpi.com
While aspirin may offer protection, other non-aspirin non-steroidal anti-inflammatory drugs
(NSAIDs) can cause serious cardiovascular side effects and complications. This has led to a …

[HTML][HTML] Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue

Z Varga, S rafay ali Sabzwari, V Vargova - Cureus, 2017 - ncbi.nlm.nih.gov
Nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs with analgesic, anti-inflammatory,
and antipyretic activity. Their effect is achieved by the reduction in synthesis of prostanoids …

Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals

EL Fosbøl, F Folke, S Jacobsen… - … Quality and Outcomes, 2010 - Am Heart Assoc
Background—Studies have raised concern on the cardiovascular safety of nonsteroidal
antiinflammatory drugs (NSAIDs). We studied safety of NSAID therapy in a nationwide cohort …

Nonsteroidal anti-inflammatory drugs and cardiovascular safety–translating pharmacological data into clinical readouts

S Tacconelli, A Bruno, R Grande… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: The pharmacological management of pain includes the use of nonsteroidal anti-
inflammatory drugs (NSAIDs). They comprise traditional (t) NSAIDs and selective …

Risk of myocardial infarction and death associated with the use of nonsteroidal anti‐inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort …

EL Fosbøl, GH Gislason, S Jacobsen… - Clinical …, 2009 - Wiley Online Library
Use of some nonsteroidal anti‐inflammatory drugs (NSAIDs) is associated with increased
cardiovascular risk in several patient groups, but whether this excess risk exists in …

An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs

ME Farkouh, BP Greenberg - The American journal of cardiology, 2009 - Elsevier
Nonsteroidal anti-inflammatory drugs (NSAIDs), both nonselective and cyclooxygenase-2–
specific inhibitors, are commonly used medications for the relief of acute and chronic pain …

Non‐steroidal anti‐inflammatory drug‐induced cardiovascular adverse events: a meta‐analysis

BR Gunter, KA Butler, RL Wallace… - Journal of clinical …, 2017 - Wiley Online Library
What is known and objective Although non‐steroidal anti‐inflammatory drugs (NSAID s)
have been studied in randomized, controlled trials and meta‐analyses in an effort to …

NSAIDs and cardiovascular risk

F Marsico, S Paolillo, PP Filardi - Journal of cardiovascular …, 2017 - journals.lww.com
NSAIDs are the most largely used class of drugs in the world, due to their large use in many
diseases, in particular for the systemic inflammatory diseases. Nevertheless, today NSAIDs …